Barrington Research analyst Alexander Paris maintains Stack Capital Group (TSX:STCK) with a Outperform and lowers the price target from C$10 to C$9.
CORRECTION: Panbela Announces Pricing Of ~$8.5M Public Offering Of 2.27M Shares Of Common Stock Or Pre-Funded Warrants In Lieu Thereof And Two Classes Of Warrants To Purchase Up To An Aggregate Of 4.54M Shares Of Its Common Stock At A Price Of $3.75/Sh…
Panbela Therapeutics, Inc. (NASDAQ:PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced the pricing of a
